125 related articles for article (PubMed ID: 15039531)
1. Proliferation and differentiation in isogenic populations of peripheral B cells activated by Epstein-Barr virus or T cell-derived mitogens.
O'Nions J; Allday MJ
J Gen Virol; 2004 Apr; 85(Pt 4):881-895. PubMed ID: 15039531
[TBL] [Abstract][Full Text] [Related]
2. Induction of interferon-stimulated genes on the IL-4 response axis by Epstein-Barr virus infected human b cells; relevance to cellular transformation.
Smith N; Tierney R; Wei W; Vockerodt M; Murray PG; Woodman CB; Rowe M
PLoS One; 2013; 8(5):e64868. PubMed ID: 23724103
[TBL] [Abstract][Full Text] [Related]
3. Murine B1 B cells require IL-5 for optimal T cell-dependent activation.
Erickson LD; Foy TM; Waldschmidt TJ
J Immunol; 2001 Feb; 166(3):1531-9. PubMed ID: 11160193
[TBL] [Abstract][Full Text] [Related]
4. Interleukin 15-mediated induction of cytotoxic effector cells capable of eliminating Epstein-Barr virus-transformed/immortalized lymphocytes in culture.
Sharif-Askari E; Fawaz LM; Tran P; Ahmad A; Menezes J
J Natl Cancer Inst; 2001 Nov; 93(22):1724-32. PubMed ID: 11717333
[TBL] [Abstract][Full Text] [Related]
5. Human B lymphocytes activated by Epstein-Barr virus (EBV) or by mitogens suppress mitogen-induced immunoglobulin production.
Tsukuda K; Berczi I; Klein G
J Immunol; 1981 May; 126(5):1810-3. PubMed ID: 6260858
[TBL] [Abstract][Full Text] [Related]
6. Induction of latent membrane protein expression in in vitro Epstein-Barr virus-infected leukaemic B lymphocytes by interleukin 4 and antibodies to CD40.
Crawford DH; Thomas JA; Gregory CD; Catovsky D; Chaggar K
Leukemia; 1995 May; 9(5):747-53. PubMed ID: 7539512
[TBL] [Abstract][Full Text] [Related]
7. Cell surface phenotyping and cytokine production of Epstein-Barr Virus (EBV)-transformed lymphoblastoid cell lines (LCLs).
Wroblewski JM; Copple A; Batson LP; Landers CD; Yannelli JR
J Immunol Methods; 2002 Jun; 264(1-2):19-28. PubMed ID: 12191505
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus infection and mitogen stimulation of normal B cells induces wild-type p53 without subsequent growth arrest or apoptosis.
Pokrovskaja K; Okan I; Kashuba E; L Wbeer M; Klein G; Szekely L
J Gen Virol; 1999 Apr; 80 ( Pt 4)():987-995. PubMed ID: 10211969
[TBL] [Abstract][Full Text] [Related]
9. Characteristics and responses of EBV immortalized B cells from periodontal disease patients.
Celenligil H; Ebersole JL
Oral Dis; 1997 Dec; 3(4):262-71. PubMed ID: 9643223
[TBL] [Abstract][Full Text] [Related]
10. Effects of IL-4, IL-5, and IL-6 on growth and immunoglobulin production of Epstein-Barr virus-infected human B cells.
Bende RJ; Jochems GJ; Frame TH; Klein MR; van Eijk RV; van Lier RA; Zeijlemaker WP
Cell Immunol; 1992 Sep; 143(2):310-23. PubMed ID: 1324802
[TBL] [Abstract][Full Text] [Related]
11. A division-linked mechanism for the rapid generation of Ig-secreting cells from human memory B cells.
Tangye SG; Avery DT; Hodgkin PD
J Immunol; 2003 Jan; 170(1):261-9. PubMed ID: 12496408
[TBL] [Abstract][Full Text] [Related]
12. In vitro transformation by Epstein-Barr virus induces a switch in growth factor and anti-IgM responsiveness in a human leukemic B cell clone.
Janssen O; Gillis S; Kabelitz D
Eur J Immunol; 1990 Jan; 20(1):7-14. PubMed ID: 2155117
[TBL] [Abstract][Full Text] [Related]
13. Effects of phorbol esters and cytokines (interleukin-2,-4, and -6) on the proliferation and surface phenotype of Epstein-Barr virus immortalised human B lymphocytes.
Kosmas C; Epenetos AA; Courtenay-Luck NS
Leuk Lymphoma; 1992 Sep; 8(1-2):109-15. PubMed ID: 1337296
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of interleukin-4 induction and interferon-gamma inhibition of IgE secretion by Epstein-Barr virus-infected human peripheral blood B cells.
Thyphronitis G; Banchereau J; Heusser C; Tsokos GC; Levine AD; Finkelman FD
Cell Immunol; 1991 Apr; 133(2):408-19. PubMed ID: 1849800
[TBL] [Abstract][Full Text] [Related]
15. Proliferation and differentiation of human CD5+ and CD5- B cell subsets activated through their antigen receptors or CD40 antigens.
Defrance T; Vanbervliet B; Durand I; Briolay J; Banchereau J
Eur J Immunol; 1992 Nov; 22(11):2831-9. PubMed ID: 1385152
[TBL] [Abstract][Full Text] [Related]
16. CD40 ligand-positive CD8+ T cell clones allow B cell growth and differentiation.
Hermann P; Van-Kooten C; Gaillard C; Banchereau J; Blanchard D
Eur J Immunol; 1995 Oct; 25(10):2972-7. PubMed ID: 7589100
[TBL] [Abstract][Full Text] [Related]
17. Plasmacytoid differentiation of Epstein-Barr virus-transformed B cells in vivo is associated with reduced expression of viral latent genes.
Rochford R; Hobbs MV; Garnier JL; Cooper NR; Cannon MJ
Proc Natl Acad Sci U S A; 1993 Jan; 90(1):352-6. PubMed ID: 8380497
[TBL] [Abstract][Full Text] [Related]
18. Antigen presentation by human B cells: T cell proliferation induced by Epstein Barr virus B lymphoblastoid cells.
Issekutz T; Chu E; Geha RS
J Immunol; 1982 Oct; 129(4):1446-50. PubMed ID: 6286767
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease.
Dolcetti R; Frisan T; Sjöberg J; De Campos-Lima PO; Pisa P; De Re V; Gloghini A; Rizzo S; Masucci MG; Boiocchi M
Cancer Res; 1995 Aug; 55(16):3675-81. PubMed ID: 7627978
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus infection of naïve B cells in vitro frequently selects clones with mutated immunoglobulin genotypes: implications for virus biology.
Heath E; Begue-Pastor N; Chaganti S; Croom-Carter D; Shannon-Lowe C; Kube D; Feederle R; Delecluse HJ; Rickinson AB; Bell AI
PLoS Pathog; 2012; 8(5):e1002697. PubMed ID: 22589726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
